NeuroAge Therapeutics

San Francisco, United States

NeuroAge Therapeutics is a longevity biotech firm that develops new medications to regenerate biological brain aging.

$250K raised

Feb 2024

Grant

Health Care Health Diagnostics

Top Investors

Alzheimer's Drug Discovery Foundation

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about NeuroAge Therapeutics

How much funding has NeuroAge Therapeutics raised?

NeuroAge Therapeutics has raised $250K in total funding. The most recent round was Grant. The last funding was announced in February 2024.

Who are NeuroAge Therapeutics's investors?

NeuroAge Therapeutics's investors include Alzheimer's Drug Discovery Foundation.

Where is NeuroAge Therapeutics headquartered?

NeuroAge Therapeutics is headquartered in San Francisco, United States.

What does NeuroAge Therapeutics do?

NeuroAge Therapeutics is a longevity biotech firm that develops new medications to regenerate biological brain aging.

What stage is NeuroAge Therapeutics at?

NeuroAge Therapeutics is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated February 21, 2024.

MLA

"NeuroAge Therapeutics — Funding & Investors." VCBacked, February 21, 2024, https://www.vcbacked.co/company/neuroage-therapeutics. Accessed July 3, 2026.

APA

VCBacked. (2024). NeuroAge Therapeutics — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/neuroage-therapeutics

Wikipedia (cite web)

{{cite web |title=NeuroAge Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/neuroage-therapeutics |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated February 21, 2024.